Search details
1.
The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis.
PLoS Pathog
; 16(1): e1008236, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31971984
2.
Vaginal cytokine profile and microbiota before and after lubricant use compared with condomless vaginal sex: a preliminary observational study.
BMC Infect Dis
; 21(1): 973, 2021 Sep 18.
Article
in English
| MEDLINE | ID: mdl-34537015
3.
Engineering monoclonal antibody-based contraception and multipurpose prevention technologies.
Biol Reprod
; 103(2): 275-285, 2020 08 04.
Article
in English
| MEDLINE | ID: mdl-32607584
4.
Vaginal microbiota and sexually transmitted infections that may influence transmission of cell-associated HIV.
J Infect Dis
; 210 Suppl 3: S616-21, 2014 Dec 15.
Article
in English
| MEDLINE | ID: mdl-25414415
5.
Evaluation of microbicide gel adherence monitoring methods.
Sex Transm Dis
; 39(5): 335-40, 2012 May.
Article
in English
| MEDLINE | ID: mdl-22504592
6.
In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide.
BMC Infect Dis
; 11: 200, 2011 Jul 19.
Article
in English
| MEDLINE | ID: mdl-21771337
7.
Observational cohort study of the effect of a single lubricant exposure during transvaginal ultrasound on cell-shedding from the vaginal epithelium.
PLoS One
; 16(5): e0250153, 2021.
Article
in English
| MEDLINE | ID: mdl-33939727
8.
Rapid fluctuation of the vaginal microbiota measured by Gram stain analysis.
Sex Transm Infect
; 86(4): 297-302, 2010 Aug.
Article
in English
| MEDLINE | ID: mdl-20660593
9.
Cervicovaginal fluid and semen block the microbicidal activity of hydrogen peroxide produced by vaginal lactobacilli.
BMC Infect Dis
; 10: 120, 2010 May 19.
Article
in English
| MEDLINE | ID: mdl-20482854
10.
Microbicide excipients can greatly increase susceptibility to genital herpes transmission in the mouse.
BMC Infect Dis
; 10: 331, 2010 Nov 18.
Article
in English
| MEDLINE | ID: mdl-21087496
11.
Formulating a sulfonated antiviral dendrimer in a vaginal microbicidal gel having dual mechanisms of action.
Drug Dev Ind Pharm
; 35(5): 515-24, 2009 May.
Article
in English
| MEDLINE | ID: mdl-19040181
12.
Development of rectal enema as microbicide (DREAM): Preclinical progressive selection of a tenofovir prodrug enema.
Eur J Pharm Biopharm
; 138: 23-29, 2019 May.
Article
in English
| MEDLINE | ID: mdl-29802984
13.
Conceptual Design of a Universal Donor Screening Approach for Vaginal Microbiota Transplant.
Front Cell Infect Microbiol
; 9: 306, 2019.
Article
in English
| MEDLINE | ID: mdl-31555606
14.
Hyperosmolal vaginal lubricants markedly reduce epithelial barrier properties in a three-dimensional vaginal epithelium model.
Toxicol Rep
; 5: 134-140, 2018.
Article
in English
| MEDLINE | ID: mdl-29854584
15.
Anti-HIV-1 Activity of Lactic Acid in Human Cervicovaginal Fluid.
mSphere
; 3(4)2018 07 05.
Article
in English
| MEDLINE | ID: mdl-29976641
16.
Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent.
J Clin Invest
; 109(2): 205-11, 2002 Jan.
Article
in English
| MEDLINE | ID: mdl-11805132
17.
Special focus issue: passive immunization.
Hum Vaccin Immunother
; 18(2): 2028517, 2022 04 29.
Article
in English
| MEDLINE | ID: mdl-35507828
18.
The role of lactic acid production by probiotic Lactobacillus species in vaginal health.
Res Microbiol
; 168(9-10): 782-792, 2017.
Article
in English
| MEDLINE | ID: mdl-28435139
19.
Vaginal microbicides: detecting toxicities in vivo that paradoxically increase pathogen transmission.
BMC Infect Dis
; 6: 90, 2006 Jun 01.
Article
in English
| MEDLINE | ID: mdl-16740164
20.
Diffusion of Immunoglobulin G in Shed Vaginal Epithelial Cells and in Cell-Free Regions of Human Cervicovaginal Mucus.
PLoS One
; 11(6): e0158338, 2016.
Article
in English
| MEDLINE | ID: mdl-27362256